These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15005421)

  • 21. Chemical synthesis and structural characterization of the RGD-protein decorsin: a potent inhibitor of platelet aggregation.
    Polverino de Laureto P; Scaramella E; De Filippis V; Marin O; Doni MG; Fontana A
    Protein Sci; 1998 Feb; 7(2):433-44. PubMed ID: 9521121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward a novel class of antithrombotic compounds with dual function. Discovery of 1,4-benzoxazin-3(4H)-one derivatives possessing thrombin inhibitory and fibrinogen receptor antagonistic activities.
    Stefanic Anderluh P; Anderluh M; Ilas J; Mravljak J; Sollner Dolenc M; Stegnar M; Kikelj D
    J Med Chem; 2005 May; 48(9):3110-3. PubMed ID: 15857114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure.
    Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S
    Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity.
    Alexopoulos K; Matsoukas J; Tselios T; Roumelioti P; Mavromoustakos T; Holada K
    Amino Acids; 1998; 15(3):211-20. PubMed ID: 9871500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a novel potent peptidyl platelet preserving agent: molecular design and biologic activity.
    Ozeki E; Matsuda T
    ASAIO Trans; 1990; 36(3):M562-4. PubMed ID: 2252751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
    Wittig K; Rothe G; Schmitz G
    Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
    Xie Z; Feng S; Wang Y; Cao C; Huang J; Chen Y; Kong Y; Li Z
    Eur J Med Chem; 2015 Sep; 102():363-74. PubMed ID: 26298494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.
    Wong A; Hwang SM; Johanson K; Samanen J; Bennett D; Landvatter SW; Chen W; Heys JR; Ali FE; Ku TW; Bondinell W; Nichols AJ; Powers DA; Stadel JM
    J Pharmacol Exp Ther; 1998 Apr; 285(1):228-35. PubMed ID: 9536015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists.
    Malovichko OL; Petrus AS; Krysko AA; Kabanova TA; Andronati SA; Karaseva TL; Kiriyak AV
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5294-7. PubMed ID: 16919941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric derivative of fibrolase, a fibrinolytic enzyme from southern copperhead venom, possesses inhibitory activity on platelet aggregation.
    Swenson S; Bush LR; Markland FS
    Arch Biochem Biophys; 2000 Dec; 384(2):227-37. PubMed ID: 11368309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel fibrinogen receptor antagonists--RGDF mimetics, 4-(1,2,3,4-tetrahydro-isoquinoline-7-yl)amino-4-oxo-butyric acid derivatives.
    Krysko AA; Malovichko OL; Andronati SA; Kabanova TA; Karaseva TL; Petrus AS
    Med Chem; 2006 May; 2(3):295-8. PubMed ID: 16948476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synthesis of alternative diketopiperazines as potential RGD mimetics.
    Mihala N; Csámpai A; Ilas J; Kikelj D; Kiss R; Süli-Vargha H
    J Pept Sci; 2006 Oct; 12(10):663-9. PubMed ID: 16835887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the synthesis and activities of RGD related peptides].
    Zhao M; Peng SQ; Dilinuer S; Wang YY; Zhou QL; Zhao WZ
    Yao Xue Xue Bao; 1997 Apr; 32(4):271-7. PubMed ID: 11499029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of RGD-containing peptides on platelet aggregation].
    Vasil'eva TM; Makarov VA; Petrukhina GN; Voiushina TL; Iusupova MP; Novgorodova SA; Kotlova EK
    Eksp Klin Farmakol; 2006; 69(4):39-42. PubMed ID: 16995437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anti-aggregatory activity of linear retro-inverso RGD peptides.
    Dal Pozzo A; Fagnoni M; Bergonzi R; Vanini L; de Castiglione R; Aglio C; Colli S
    J Pept Res; 2000 Jun; 55(6):447-54. PubMed ID: 10888201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
    Liu J; Zhao M; Wang C; Peng S
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4065-9. PubMed ID: 14592509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of high-affinity P2Y₁₂ antagonists based on a phenylpyrazole glutamic acid piperazine backbone.
    Zech G; Hessler G; Evers A; Weiss T; Florian P; Just M; Czech J; Czechtizky W; Görlitzer J; Ruf S; Kohlmann M; Nazaré M
    J Med Chem; 2012 Oct; 55(20):8615-29. PubMed ID: 22984835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjugation to hyperbranched polyglycerols improves RGD-mediated inhibition of platelet function in vitro.
    Zhang JG; Krajden OB; Kainthan RK; Kizhakkedathu JN; Constantinescu I; Brooks DE; Gyongyossy-Issa MI
    Bioconjug Chem; 2008 Jun; 19(6):1241-7. PubMed ID: 18476729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of new N,N'-substituted piperazines on thrombin-induced platelet activation].
    Veselkina OC; Petrishchev NN; Vasina LV; Borovitov ME; Seliutin AV; Chepanov SV; Sel'kov SA
    Eksp Klin Farmakol; 2014; 77(8):28-33. PubMed ID: 25335388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.